Preparation and characteristics of thermoresponsive gel of minocycline hydrochloride and evaluation of its effect on experimental periodontitis models

Abstract In this study, a thermoresponsive gel for minocycline (MCL) with chitosan/β-glycerophosphate (C/β-GP) was formulated and its characterization, in vitro release, stability, toxicity and pharmacodynamics were investigated. The formulation containing MCL was prepared by pouring the chitosan solution directly onto the sterilized drug powder and stirring before mixing with the β-glycerophosphate (β-GP) solution. The final preparations contained 0.5% (w/v) chitosan, 1.8% (w/v) β-GP and 2% (w/v) MCL. The drug content of prepared gels was in the range of 92–99%, and the pH value of the optimized formulation was found to be 5.6–6.2. The gelation temperature of the prepared C/β-GP thermogelling solutions was 37 °C. Color, consistency, pH, viscosity and drug content of the in situ gels were found to be consistent, and no signs of separation and deterioration were observed over a period of 90 d. In vivo studies showed that rats' liver and kidney tissue sections were normal, with no structural damage. The constituents of the in situ gels formulation had a well-sustained release efficacy on the animal model of periodontitis.

[1]  Liandong Deng,et al.  Thermosensitive in situ hydrogel based on the hybrid of hyaluronic acid and modified PCL/PEG triblock copolymer. , 2014, Carbohydrate polymers.

[2]  N. Mignet,et al.  Influence of additives on a thermosensitive hydrogel for buccal delivery of salbutamol: relation between micellization, gelation, mechanic and release properties. , 2014, International journal of pharmaceutics.

[3]  M. Tonetti,et al.  Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. , 2013, The Journal of Periodontology.

[4]  Ritu Jain,et al.  Minocycline containing local drug delivery system in the management of chronic periodontitis: A randomized controlled trial , 2012, Journal of Indian Society of Periodontology.

[5]  Haruo Watanabe,et al.  Impact of minocycline ointment for periodontal treatment of oral bacteria. , 2011, Japanese journal of infectious diseases.

[6]  Wei Wu,et al.  [Doxycycline nano-liposome slow-release gel improves rat periodontitis]. , 2010, Shanghai kou qiang yi xue = Shanghai journal of stomatology.

[7]  Wei Wei,et al.  A comparative study of systemic subantimicrobial and topical treatment of minocycline in experimental periodontitis of rats. , 2006, Archives of oral biology.

[8]  S. Anil,et al.  The impact of periodontal infections on systemic diseases. An update for medical practitioners. , 2006, Saudi medical journal.

[9]  T. Kristmundsdottir,et al.  Development of a simple HPLC method for separation of doxycycline and its degradation products. , 2003, Journal of pharmaceutical and biomedical analysis.

[10]  L. Jin,et al.  Are periodontal diseases risk factors for certain systemic disorders--what matters to medical practitioners? , 2003, Hong Kong medical journal = Xianggang yi xue za zhi.

[11]  C. Rossa Junior,et al.  Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats. , 2002, Journal of periodontology.

[12]  J. Leroux,et al.  Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Henry H. Takei Perry R. Klokkevold Michael G. Newman Carranza's Clinical Periodontology , 2001 .

[14]  M. Trevisan,et al.  Periodontal infections contribute to elevated systemic C-reactive protein level. , 2001, Journal of periodontology.

[15]  Dong Wang,et al.  Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions , 2001 .

[16]  J. Leroux,et al.  Novel injectable neutral solutions of chitosan form biodegradable gels in situ. , 2000, Biomaterials.

[17]  J. Leroux,et al.  Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. , 2000, International journal of pharmaceutics.

[18]  R. Page,et al.  The host response to the microbial challenge in periodontitis: assembling the players. , 1997, Periodontology 2000.

[19]  R. Brooke,et al.  An unusual case of oral pigmentation. , 1984, Oral surgery, oral medicine, and oral pathology.

[20]  B. Cooperman,et al.  Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photoproducts and implications for the inhibitory action of tetracycline on protein synthesis. , 1983, Biochemistry.

[21]  W. Higuchi,et al.  Analysis of data on the medicament release from ointments. , 1962, Journal of pharmaceutical sciences.

[22]  J. Slots Systemic antibiotics in periodontics. , 2004, Journal of periodontology.

[23]  J. Leroux,et al.  Effects of steam sterilization on thermogelling chitosan-based gels. , 2001, Journal of biomedical materials research.

[24]  W. Ketterl [Periodontal diseases]. , 1971, Der Zahnarzt; Colloquium med. dent.